Dong Sung Bio Pharm.Co.,Ltd.

Simbol: 002210.KS

KSC

5240

KRW

Tržna cena danes

  • -57.7739

    Razmerje P/E

  • -0.8344

    Razmerje PEG

  • 119.82B

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Dong Sung Bio Pharm.Co.,Ltd. (002210-KS) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Dong Sung Bio Pharm.Co.,Ltd. (002210.KS). Prihodki podjetja prikazujejo povprečje 79053.1 M, ki je 0.019 % gowth. Povprečni bruto dobiček za celotno obdobje je 37951.544 M, ki je 0.044 %. Povprečno razmerje bruto dobička je 0.488 %. Rast čistega dobička za lanskoletno poslovanje podjetja je -0.023 %, kar je enako -3.260 % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Dong Sung Bio Pharm.Co.,Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na 0. Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini 0.068. Na področju kratkoročnih sredstev 002210.KS znaša 60814.86 v valuti poročanja. Velik del teh sredstev, natančneje 6435.381, je v denarju in kratkoročnih naložbah. V tem segmentu se je ob primerjavi s podatki za preteklo leto spremenil za 0.572%. Dolgoročne naložbe podjetja, ki sicer niso v središču njegovega zanimanja, znašajo 7719.611, če obstajajo, v valuti poročanja. To pomeni razliko v višini 1413.020% glede na zadnje obdobje poročanja, kar odraža strateške premike družbe. Dolgoročni profil podjetja kaže skupni dolgoročni dolg v višini 18522.411 v valuti poročanja. Ta številka pomeni medletno spremembo v višini 0.168%. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo 39802.314 v valuti poročanja. Letna sprememba tega vidika je -0.070%. Podrobnejši pregled finančnih podatkov podjetja razkrije dodatne podrobnosti. Neto terjatve so ovrednotene na 31290.912, zaloge na 19477.06, dobro ime pa na 0, če obstaja. Celotna neopredmetena sredstva, če so prisotna, so ovrednotena z vrednostjo 978.8. Obveznosti in kratkoročni dolgovi so 1519.79 oziroma {{short_term_deby}}. Celotni dolg je 43272.81, neto dolg pa je 36837.43. Druge kratkoročne obveznosti znašajo 8850.2 in se dodajo k skupnim obveznostim 75170.97. Nazadnje se navedena zaloga vrednoti po vrednosti {{preffered_stock}}, če obstaja.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

21733.896435.44093.85142.8
23422.8
22853.6
32227.5
17931.1
20164.6
23372.6
32212
21256.9
22025
16438.8
19043.9
13732.7
15065.4
14838.1

balance-sheet.row.short-term-investments

-3073.9002002.6
9070.6
18575.2
30016.6
13883.4
17259.3
18723.2
25038.6
13965.1
12213.2
8291.3
11649
10807.9
9824
9074.7

balance-sheet.row.net-receivables

127499.5431290.935361.629324.5
27803
33260.6
38202.1
40257.5
42048.1
42684.4
42077.5
45207.2
50487.8
47433.6
46332.3
50017.4
0
0

balance-sheet.row.inventory

72346.5219477.114933.815519.1
20281.7
23283.5
17359.9
16332.3
14867.5
10963.6
12785.2
12686.7
11641
11175.6
10554
12081.5
10325.4
10173.4

balance-sheet.row.other-current-assets

16601.773611.500
0
0
0
0
0
0
0
0
0
0
0
0
47178.3
45183.5

balance-sheet.row.total-current-assets

238181.7260814.954389.249986.3
71507.5
79397.7
87789.5
74520.9
77080.3
77020.7
87074.7
79150.9
84153.8
75047.9
75930.1
75831.7
72569
70195

balance-sheet.row.property-plant-equipment-net

172690.3242725.543960.437377.8
37312.9
34175.6
34506.9
34401.7
33214.2
31883.3
32171.2
32198.6
32176.9
30617.4
47157.2
47700
48247.6
28254.1

balance-sheet.row.goodwill

0000
0
0
0
282.9
282.9
282.9
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

3645.02978.8855.8942.7
830
738.8
882.3
903.8
705.4
770.6
453.7
751.4
834.7
1166.2
741.6
812.2
758.4
168.3

balance-sheet.row.goodwill-and-intangible-assets

3645.02978.8855.8942.7
830
738.8
882.3
1186.7
988.3
1053.5
453.7
751.4
834.7
1166.2
741.6
812.2
758.4
168.3

balance-sheet.row.long-term-investments

12525.067719.6510.2-1606.9
-8716.9
-18210.1
-27258.5
-13329.7
-16749.5
-18230.4
-24858.4
-13364.9
-10407.8
-6772.6
-10083.5
-8450.2
-7736.9
-6393.6

balance-sheet.row.tax-assets

11078.520-510.217882
24784.6
1158
809.3
27405.3
30853.2
32389
39163.8
28163.8
26683.1
24518.2
1328
373.8
53.3
1568.7

balance-sheet.row.other-non-current-assets

18636.952734.68496.60
0
34470.4
43466.5
0
0
0
259
190.5
192.9
0
12469.5
11638.4
10678.2
9624.8

balance-sheet.row.total-non-current-assets

218575.8754158.453312.954595.6
54210.7
52332.8
52406.6
49664
48306.1
47095.4
47189.4
47939.5
49479.8
49529.2
51612.8
52074.2
52000.5
33222.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

456757.59114973.3107702.1104581.9
125718.2
131730.5
140196.1
124184.9
125386.4
124116.1
134264.1
127090.4
133633.7
124577.1
127542.9
127905.9
124569.6
103417.4

balance-sheet.row.account-payables

47580.1611261.188526858.8
9728.6
9978.2
10187.4
11453.5
11100.1
10338.4
12800.3
9054.1
13850.8
12397.7
12104.5
9421.3
9676.3
9543.9

balance-sheet.row.short-term-debt

112670.1924732.52927419714
14046.3
15852.6
20309.8
19183
20096.3
37463.6
37596.6
37103.8
34787.3
33294.7
29964.6
29546.8
20037.7
24325.2

balance-sheet.row.tax-payables

66.530418.8262.1
103.7
322.6
469.1
341.4
455.4
513.2
9875
576.1
678.6
784.5
4748.7
550.1
665.8
1489.1

balance-sheet.row.long-term-debt-total

52132.3418522.47761.99600.8
12349.1
11875.4
22342.7
12040.9
19971.1
2021.6
2460.6
1683.5
3206.1
1635.5
2762.5
1631.5
6718.3
7056.1

Deferred Revenue Non Current

17174.1117.909113.3
8388.2
0
0
10756.2
10719.1
9469.4
9849
9519.5
8976.9
9112.3
0
0
9677.1
0

balance-sheet.row.deferred-tax-liabilities-non-current

10739.73---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

60212.78850.29183.73729.5
4560.3
3600.9
16172.8
0
0
0
0
0
0
0
0
4228.3
5640
0

balance-sheet.row.total-non-current-liabilities

95537.1530327.117321.620552.3
22937
21082.6
35572.5
23230.1
31304.9
13116.3
13709.6
12889.9
15153.5
13456
17365.4
16189.6
20726.8
18198.2

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

231.8117.9104.155.7
70.1
78.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

289693.77517164892.858141.5
70770.1
61632.1
82711.7
59914.2
69765.8
66380.9
78658.9
65610.9
70751.4
64375.9
68858.5
59936.1
56746.7
57278.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

104403.88261012610126101
26101
26070.7
24756.6
24756.6
22404.8
22404.8
21766.5
21766.5
21128.2
21128.2
21128.2
21128.2
21128.2
21128.2

balance-sheet.row.retained-earnings

4190.1-3006.91153.1-2570.8
-10992
-779.4
7493.8
17847.1
18019.1
20133.6
19497.9
31220
34114.3
31913.1
10768.2
19250.2
19226.6
16114.7

balance-sheet.row.accumulated-other-comprehensive-income-loss

11151.022787.82787.82787.8
2787.8
5745.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

47318.8913920.512767.520122.4
37051.3
39061.9
25234.1
21667
15196.8
15196.8
14340.9
8493
7639.8
7159.9
26788.1
27591.4
27468.1
8896.1

balance-sheet.row.total-stockholders-equity

167063.8939802.342809.346440.4
54948
70098.4
57484.4
64270.7
55620.6
57735.2
55605.2
61479.4
62882.2
60201.2
58684.4
67969.8
67822.9
46138.9

balance-sheet.row.total-liabilities-and-stockholders-equity

456757.59114973.3107702.1104581.9
125718.2
131730.5
140196.1
124184.9
125386.4
124116.1
134264.1
127090.4
133633.7
124577.1
127542.9
127905.9
124569.6
103417.4

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

167063.8939802.342809.346440.4
54948
70098.4
57484.4
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

456757.59---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

9451.157719.6510.2395.7
353.8
365.1
2758.1
553.7
509.8
492.8
180.2
600.2
1805.4
1518.6
1565.6
2357.7
2087.1
2681.1

balance-sheet.row.total-debt

164820.3943272.837035.829314.8
26395.4
27727.9
42652.5
31223.9
40067.4
39485.1
40057.2
38787.3
37993.4
34930.2
32727.1
31178.3
26756.1
31381.3

balance-sheet.row.net-debt

147179.1636837.43294226174.6
12043.3
23449.5
40441.5
27176.2
37162.1
34835.7
32883.9
31495.5
28181.5
26782.7
25332.3
28253.5
21514.7
25617.9

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Dong Sung Bio Pharm.Co.,Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v -0.153. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo 0, kar kaže na razliko 0.000 v primerjavi s prejšnjim letom. Zanimivo je, da je del delnic podjetja, natančneje 0, odkupilo podjetje samo. To dejanje je povzročilo spremembo v 0.000 v primerjavi s prejšnjim letom. Medtem pa obveznosti podjetja trenutno znašajo 1519.79 v valuti poročanja. Družba je pri naložbenju porabila neto denarna sredstva v višini -927712649.000 v valuti poročanja. To je premik za -2.453 v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila 2045.99, 35.2 in -1229.62, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila 0.000, pri čemer je razlika v primerjavi z letom prej znašala 0.000. Poleg tega je podjetje namenilo 0 za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane 8796.97, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

-2073.91-2073.9-2121.7-4312.8
-14079.1
-8385.2
-5744.6
-198.3
-1660.4
454.8
-10946.9
-1988.2
3192.1
1701.1
-7937.3
568.4
3656.6
2656

cash-flows.row.depreciation-and-amortization

2082.0920462119.72222.6
2098
2107.6
1986.4
1813.1
1644.8
1608.8
1542.3
1464.9
1589.5
1507.5
1560.1
1316
1386
1465.2

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-5165.38-5165.4-4348.3-2543.3
6519.5
-5843.7
205.4
-2069.5
-5864.9
-1349.2
1103.1
-4427.2
-904.2
-7049
5759
-9896.1
-5890.6
-2527.9

cash-flows.row.account-receivables

2887.72887.7-4280.9-1791.5
4836.5
3282.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-3965.32-3965.3629.74466.7
2926
-6132
-1029.8
-2785.5
-4451.6
1084.9
-517.8
-1045.7
-680.8
-621.6
1523.2
-1781.5
-274.3
-676.4

cash-flows.row.account-payables

1519.791519.81995-2870.6
-247.9
-212.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-5607.55-5607.6-2692.1-2348
-995.2
-2781.9
1235.3
716
-1413.3
-2434.1
1620.9
-3381.4
-223.4
-6427.3
4235.7
-8114.5
-5616.3
-1851.5

cash-flows.row.other-non-cash-items

863.87900467.61882
10471.3
3815.3
4945.9
2253.4
2536.2
-10034
11951.8
2382.9
-1072.8
1197.1
5253.1
2990.7
482.7
1324.1

cash-flows.row.net-cash-provided-by-operating-activities

-4293.33000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-923.56-923.6-642.9-2323.5
-6922
-1422
-2126.8
-3004.3
-2841.6
-646.6
-1287.8
-1188.2
-1844.7
-828.6
-947
-949.5
-1102.7
-2439.2

cash-flows.row.acquisitions-net

32.7818.274.3-197.7
2143
-99.8
197
-372.3
-104.3
65.2
-23.4
150
-209.7
-437.9
-91.6
-215.7
6920.3
4119.6

cash-flows.row.purchases-of-investments

-48.49-57.5-56.2-10994.9
-51719.5
-73608.5
-92696.8
-32995.6
-51496.2
-55896.9
-64928.1
-26577.1
-33572
-39760.5
-53803.5
-15120.5
-3890.8
-11066

cash-flows.row.sales-maturities-of-investments

-32.7802019.914989.6
49947.7
84373
75772.1
36717.9
53038.9
63234.6
54421.7
26652
29342.4
43526.7
53884.3
14795
2930.3
1474.4

cash-flows.row.other-investing-activites

44.3435.2-756.9-11173.2
912.2
103.6
-210.1
211.3
470.2
-317.3
-99
-398.3
14.5
903.3
555.7
46.6
381.7
-39.9

cash-flows.row.net-cash-used-for-investing-activites

-927.71-927.7638.3-9699.8
-5638.6
9346.4
-19064.6
557.1
-933
6439
-11916.6
-1361.5
-6269.4
3403
-402.2
-1444.1
5238.8
-7951.1

cash-flows.row.debt-repayment

-33936.52-1229.6-44052.3-26435.5
-27917.2
-27580.9
-25413
-19854.5
-37660.6
-30941.4
-12680.8
-14519.2
-13774.7
-12949.5
-16046.8
-7237.7
-4625.2
-12274.3

cash-flows.row.common-stock-issued

0008455.4
-1.4
-26.3
0
0
0
1494.2
7164
1491.5
0
0
17430.4
0
0
2784.3

cash-flows.row.common-stock-repurchased

00-1996.4-2990.4
-2000.3
0
0
0
0
0
14080.4
15054.9
0
0
-899.3
0
0
12470

cash-flows.row.dividends-paid

000-8455.4
-1.4
0
0
0
0
0
-548.9
-529.7
-529.7
-529.7
-544.7
-544.7
-544.7
-685.5

cash-flows.row.other-financing-activites

41503.8887975028930657.7
26617.6
28619.3
41226.4
18866.8
40117.7
29673.1
-58
40
19797.4
13333.8
297.9
11931
-225.6
-53

cash-flows.row.net-cash-used-provided-by-financing-activities

7567.357567.44240.21231.8
-3302.6
1012.1
15813.4
-987.7
2457.2
225.9
7956.6
1537.5
5492.9
-145.4
237.4
4148.5
-5395.6
2241.5

cash-flows.row.effect-of-forex-changes-on-cash

-4.71-4.7-42.37.6
-83.4
14.9
21.2
-225.8
76.1
130.6
191.4
-128.4
-363.8
138.4
0
0
0
0

cash-flows.row.net-change-in-cash

2341.62341.6953.6-11211.9
-4015
2067.5
-1836.7
1142.4
-1744.1
-2524
-118.4
-2520
1664.3
752.7
4470
-2316.6
-522
-2792.3

cash-flows.row.cash-at-end-of-period

17641.236435.44093.83140.2
14352.1
4278.4
2210.9
4047.7
2905.3
4649.4
7173.4
7291.8
9811.8
8147.5
7394.8
2924.8
5241.4
5763.4

cash-flows.row.cash-at-beginning-of-period

15299.634093.83140.214352.1
18367.1
2210.9
4047.7
2905.3
4649.4
7173.4
7291.8
9811.8
8147.5
7394.8
2924.8
5241.4
5763.4
8555.7

cash-flows.row.operating-cash-flow

-4293.33-4293.3-3882.6-2751.5
5009.7
-8305.9
1393.3
1798.8
-3344.3
-9319.5
3650.2
-2567.5
2804.6
-2643.3
4634.8
-5021
-365.3
2917.3

cash-flows.row.capital-expenditure

-923.56-923.6-642.9-2323.5
-6922
-1422
-2126.8
-3004.3
-2841.6
-646.6
-1287.8
-1188.2
-1844.7
-828.6
-947
-949.5
-1102.7
-2439.2

cash-flows.row.free-cash-flow

-5216.9-5216.9-4525.5-5075.1
-1912.3
-9727.9
-733.5
-1205.5
-6186
-9966
2362.3
-3755.7
959.9
-3471.9
3687.8
-5970.5
-1468
478.1

Vrstica izkaza poslovnega izida

Prihodki Dong Sung Bio Pharm.Co.,Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za -0.051%. Bruto dobiček podjetja 002210.KS znaša 40649.65. Odhodki iz poslovanja podjetja so 40053.24 in so se v primerjavi s prejšnjim letom spremenili za -11.293%. Odhodki za amortizacijo znašajo 2045.99, kar je -0.035% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini 40053.24, ki kaže -11.293% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo 0, kar pomeni 0.000% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša 0 in predstavlja 1.292% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so 596.4, ki kažejo -1.292% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je -0.023%. Čisti prihodki v zadnjem letu so znašali -2073.91.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

88593.5988593.693328.284407.7
87799.9
86536.8
91912.7
82385.2
79720.9
74660.4
73157.9
75175.3
84581
78442.1
71926
68724.2
62231.4
60319.5

income-statement-row.row.cost-of-revenue

47447.6447943.951272.850864
53650.7
53460.2
56718.2
46281.6
42624.9
38182.4
37893.9
36210.9
42056.7
33020.8
31919.4
27614.8
25271.4
23739.8

income-statement-row.row.gross-profit

41145.9540649.642055.433543.6
34149.2
33076.5
35194.5
36103.6
37096
36477.9
35264
38964.4
42524.3
45421.3
40006.6
41109.4
36960
36579.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

4169.12---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

12376.07---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

24762.64---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-20425.25-2211220012364.1
10995.7
13821.9
243.5
327.6
796.9
479.6
-977.7
420.2
1340.9
494.9
-618.7
372.3
202.6
206.5

income-statement-row.row.operating-expenses

1866640053.245152.438842.7
37820
40608.3
37001.8
35148.5
39385.6
35281
37094.8
40931.4
39271.3
42313.6
43152.8
39979.5
35352.2
34928

income-statement-row.row.cost-and-expenses

77055.4187997.296425.289706.7
91470.7
94068.5
93719.9
81430.1
82010.5
73463.5
74988.7
77142.3
81328
75334.4
75072.2
67594.2
60623.6
58667.7

income-statement-row.row.interest-income

63.2663.347.176.7
25.5
60.4
23.6
5.9
7.8
12.1
155.1
72.7
47.3
98.5
347.5
260.9
548.2
349.1

income-statement-row.row.interest-expense

2240.912240.91307.8712.2
850.3
1403.3
1689.2
1466.7
1396.1
1423.2
1564.3
1813.4
2284.2
2002.6
2075.4
1701.4
1828.5
1965.5

income-statement-row.row.selling-and-marketing-expenses

24762.64---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-1462.29-1462.3191.2919.7
-7135.1
-1233.8
-4885.8
-1521.4
-253.4
-452.8
-1164.5
-1147.9
338.8
-1359.1
-1905.1
-454
3628.6
1819.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-20425.25-2211220012364.1
10995.7
13821.9
243.5
327.6
796.9
479.6
-977.7
420.2
1340.9
494.9
-618.7
372.3
202.6
206.5

income-statement-row.row.total-operating-expenses

-1462.29-1462.3191.2919.7
-7135.1
-1233.8
-4885.8
-1521.4
-253.4
-452.8
-1164.5
-1147.9
338.8
-1359.1
-1905.1
-454
3628.6
1819.8

income-statement-row.row.interest-expense

2240.912240.91307.8712.2
850.3
1403.3
1689.2
1466.7
1396.1
1423.2
1564.3
1813.4
2284.2
2002.6
2075.4
1701.4
1828.5
1965.5

income-statement-row.row.depreciation-and-amortization

12820.2620462119.73980.6
2256.7
3367.7
1986.4
1813.1
1644.8
1608.8
1542.3
1464.9
1589.5
1507.5
1560.1
1316
1386
1465.2

income-statement-row.row.ebitda-caps

13416.67---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

596.4596.4-2041.8-5299
-3670.8
-7531.8
-1807.3
955.1
-2289.6
1196.9
-1830.8
-1967
3253.1
3595.2
-3146.2
1129.9
1607.9
1651.8

income-statement-row.row.income-before-tax

-865.89-865.9-1850.6-4379.3
-10805.9
-8765.5
-6693.1
-566.3
-2543.1
744.1
-2995.3
-3114.9
3591.9
1748.6
-5051.3
676
5236.4
3471.5

income-statement-row.row.income-tax-expense

1208.021208271.1-66.5
3273.3
-380.3
-948.5
-368
-882.6
289.2
7951.7
-1126.7
399.8
47.5
2886.1
107.6
1579.8
815.6

income-statement-row.row.net-income

-2073.91-2073.9-2121.7-4312.8
-14079.1
-8385.2
-5744.6
-198.3
-1660.4
454.8
-10946.9
-1988.2
3192.1
1701.1
-7937.3
568.4
3656.6
2656

Pogosto zastavljeno vprašanje

Kaj je Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) skupna sredstva?

Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) skupna sredstva so 114973284037.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so 43786401591.000.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.464.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -228.151.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -0.023.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.007.

Kaj je Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -2073909512.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 43272811605.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 40053242263.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 6435381432.000.